Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
House Dust Mite Allergy - Overview
House Dust Mite Allergy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
House Dust Mite Allergy - Therapeutics Assessment
Assessment by Target
Assessment by Route of Administration
Assessment by Molecule Type
House Dust Mite Allergy - Companies Involved in Therapeutics Development
Advagene Biopharma Co Ltd
ALK-Abello AS
Allergy Therapeutics Plc
Anergis SA
Biomay AG
Genetic Immunity Inc
Polyrizon Ltd
Roxall Medizin GmbH
Stallergenes Greer Ltd
Zhejiang I-Biological Technology Co Ltd
House Dust Mite Allergy - Drug Profiles
AD-17002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Allergan for Dust Mite Allergy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AM-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BM-35 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
House Dust Mite Allergy - Dormant Projects
House Dust Mite Allergy - Discontinued Products
House Dust Mite Allergy - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development for House Dust Mite Allergy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for House Dust Mite Allergy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
House Dust Mite Allergy - Pipeline by Advagene Biopharma Co Ltd, H2 2020
House Dust Mite Allergy - Pipeline by ALK-Abello AS, H2 2020
House Dust Mite Allergy - Pipeline by Allergy Therapeutics Plc, H2 2020
House Dust Mite Allergy - Pipeline by Anergis SA, H2 2020
House Dust Mite Allergy - Pipeline by Biomay AG, H2 2020
House Dust Mite Allergy - Pipeline by Genetic Immunity Inc, H2 2020
House Dust Mite Allergy - Pipeline by Polyrizon Ltd, H2 2020
House Dust Mite Allergy - Pipeline by Roxall Medizin GmbH, H2 2020
House Dust Mite Allergy - Pipeline by Stallergenes Greer Ltd, H2 2020
House Dust Mite Allergy - Pipeline by Zhejiang I-Biological Technology Co Ltd, H2 2020
House Dust Mite Allergy - Dormant Projects, H2 2020
House Dust Mite Allergy - Discontinued Products, H2 2020